Dr Reddys lab reports 25% rise in its Q1 net profit

20 Jul 2011 Evaluate

Dr Reddys Laboratories has reported results for its first quarter ended June 30, 2011.

The company’s net profit for the quarter has surged by 25.38% at Rs 262.74 crore as compared to Rs 209.55 crore for the quarter ended June 30, 2010. Its net income from sales and services has increased by 17.54% to Rs 1978.32 crore for the quarter under review from Rs 1683.13 crore for the corresponding quarter of the previous year.

Dr Reddys, a global pharmaceutical company, has a global presence in more than 100 countries, with subsidiaries in the US, UK, Russia, Germany and Brazil; joint ventures in China, South Africa and Australia; representative offices in 16 countries and third-party distribution set ups in 21 countries.

Dr. Reddys Lab Share Price

1276.55 -0.45 (-0.04%)
05-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1520.55
Zydus Lifesciences 933.10
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×